by Patrice D. Cani
Individuals with obesity and type 2 diabetes have shown an altered gut microbiome composition. A new study has discovered tissue bacterial signatures linked to type 2 diabetes.
by Andreu Prados
Our gut microbiota profile may help us understand the contribution of bariatric surgery to weight loss. New findings reveal gut microbiota composition before Roux-en-Y gastric bypass is associated with type 2 diabetes remission in obese diabetic women.
by GMFH Editing Team
Ruling out the specific contribution of obesity and type 2 diabetes in gut microbiome variation is a challenge. Louise Thingholm and colleagues have found that while obesity is linked to gut microbiome variation, gut microbiome associations with type 2 diabetes are modest.
by Andreu Prados
Gut bacterial communities ferment non-digestible carbohydrates and as a metabolic output produce short-chain fatty acids (SCFAs) that are involved in fiber’s beneficial effects. Activities of SCFAs include not only providing an energy substrate to colonocytes, but also mitigating inflammation, regulating
by Andreu Prados
Although previous observational research has found that type 2 diabetes (T2D) is related to gut dybsiosis, a causal link between gut microbial dysbiosis and T2D development has not yet been proven. Besides this, it has been reported that treatment with
by GMFH Editing Team
Gut Microbiota for Health is pleased to announce its participation at the 21st International Congress of Nutrition (ICN). Organized by the International Union of Nutritional Sciences (IUNS) with the theme “From Sciences to Nutrition Security”, the event will take place
by Andreu Prados
It is well-known that medications could affect the microbiome and therefore host-microbiota interactions are considered a confounding factor that can contribute to therapeutic and side effects of drug treatments. Previous research has shown that gut microbiota may partially mediate both
The prevalence of type 2 diabetes (T2D) is increasingly rapidly around the globe and has challenged researchers to investigate the underlying pathophysiological mechanisms. The T2D pandemic closely tracks the rise of obesity, not only in Europe and USA but also